Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $6.83, but opened at $7.19. Aspen Pharmacare shares last traded at $7.19, with a volume of 221 shares traded.
Aspen Pharmacare Trading Up 3.9%
The firm has a fifty day simple moving average of $5.74 and a 200-day simple moving average of $5.98. The company has a current ratio of 2.21, a quick ratio of 1.18 and a debt-to-equity ratio of 0.37.
Aspen Pharmacare Company Profile
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
Further Reading
- Five stocks we like better than Aspen Pharmacare
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- First Time Since 2007: All Warnings Active
- How the Rich Retire
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
